- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02485561
Evaluating Strategies to Present Colon Cancer Screening Information
Comparing Screener vs. Survivor Role Models to Improve Colon Cancer Screening
Study Overview
Status
Intervention / Treatment
Detailed Description
The use of patient narratives in interventions and their availability on the Internet is becoming ubiquitous and has far outpaced empirical research to assess how and for whom narratives are effective. To improve future behavioral interventions that incorporate narratives, researchers need to identify the best role models to promote colon cancer screening and examine their potentially different mechanisms of influence.
For the proposed web-based, 3-arm English-language pilot intervention with a brief, 1 month follow-up, the study investigators will randomize 400 average-risk adults age 50-75 who are non-adherent to colon cancer screening guidelines and have no cancer history to one of three groups to read: 1) basic information about colon cancer risk and test options, 2) the same colon cancer and screening information plus a narrative from a colon cancer survivor, or 3) the same colon cancer and screening information plus a narrative from someone who got screened for colon cancer. To better assess behavior change, a 6 and 12 month follow up survey was added.
All participants will read general information about colon cancer and screening guidelines, test options, and benefits based on Centers for Disease Control and Prevention educational materials. Narrative participants will then view a role model that is tailored to each participant by gender, race/ ethnicity, and age group. Along with a photo will be a brief message to identify role models as colon cancer survivors or screeners. Narrative conditions will include a single role model and story of first-person experiences of colonoscopy. Participants will complete survey measures before and after the information and stories are presented and at one, 6, and 12 month follow-up. Participation in the first part of the study will take about 30 minutes and about 15 minutes for the follow up survey. Participants can complete all study requirements through our website: http://HealthStudy.wustl.edu
This study will examine potential mediators or mechanisms that explain the effects of these narratives on screening-related outcomes based on a proposed conceptual model. The study investigators will enroll a diverse sample of participants to explore any differences in narrative effects by audience characteristics (potential moderators).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Missouri
-
Saint Louis, Missouri, United States, 63110
- Washington University website HeathStudy.wustl.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male and female adults of any race or ethnicity living in the United States
- Age 50-75 years old
- Access to the Internet to complete all study requirements at http://HealthStudy.wustl.edu
Exclusion Criteria:
- Unable to read English
- Prior diagnosis of cancer (except non-melanoma skin cancer)
- Prior diagnosis of Crohn's disease, inflammatory bowel disease or colitis
- Currently adherent to colon cancer screening guidelines defined as a home-based stool blood test in the past 12 months, a sigmoidoscopy in the past 5 years, or a colonoscopy in the past 10 years.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Information only
INTERVENTION: Information about colon cancer and screening tests from sources such as the Centers for Disease Control and Prevention Screen for Life campaign.
|
Educational materials such as those from the Centers for Disease Control and Prevention are used to present educational information to participants about colon cancer and screening tests.
|
|
Experimental: Screener Narrative
INTERVENTION: Information + Personal Narrative from someone who was screened for colon cancer
|
Educational materials such as those from the Centers for Disease Control and Prevention are used to present educational information to participants about colon cancer and screening tests.
This study will compare the effects of adding narratives that describe personal experiences with colon cancer screening to educational information alone to explore potential differences in reactions to different role models on individuals' screening intentions and behaviors.
|
|
Experimental: Survivor Narrative
INTERVENTION: Information + Personal Narrative from someone who was screened for, and diagnosed with, colon cancer
|
Educational materials such as those from the Centers for Disease Control and Prevention are used to present educational information to participants about colon cancer and screening tests.
This study will compare the effects of adding narratives that describe personal experiences with colon cancer screening to educational information alone to explore potential differences in reactions to different role models on individuals' screening intentions and behaviors.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intentions to Get Screened for Colon Cancer
Time Frame: Immediately post-intervention
|
Intention was measured on all surveys with the mean of 3 items assessed using slider bars (coded 1=not at all - 100=extremely) asking about the likelihood of being screened in the next 6 months, the importance of screening, and commitment to screening.
Higher scores indicate greater intentions to get screened for colorectal cancer.
|
Immediately post-intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Identification With the Character
Time Frame: Immediately post-intervention
|
Participants assigned to narrative conditions were asked if they liked and felt similar to the character in the story they read with 3 items each with response options 1=Strongly Disagree - 5=Strongly Agree.
Measures were based on previous work by the study investigators.
Mean scores for liking and similarity were created; higher scores reflect higher perceived similarity and liking for the character.
Means will be compared between the two groups assigned to read a narrative.
|
Immediately post-intervention
|
|
Three Measures of Engagement
Time Frame: Immediately post-intervention
|
Confirmatory factor analyses did not support an aggregate measure adapted from an existing transportation scale, so a single item "What I just read affected me emotionally" was used to measure emotional engagement for all participants.
For participants assigned to either narrative condition, two items reflected cognitive (imagery) engagement "While I was reading the story, I could easily picture the events in it taking place" and "I had a vivid mental image of the person in the story".
Mean scores were created for cognitive engagement.
Two items reflected self-referencing engagement: "I could picture myself in the scene of the events described in the story" and "The events in the story are relevant to my life" were assessed and mean scores created for self-referencing engagement.
Responses for all items were 1=Not at all - 7=Very much.
Higher mean scores reflected higher engagement.
|
Immediately post-intervention
|
|
Self-efficacy for Getting Screened for Colon Cancer
Time Frame: Immediately post-intervention
|
Six items assess confidence in getting screened for colon cancer despite common barriers.
Mean scores are created from response options that range from 1=not at all confident to 7=very confident.
Higher scores reflect greater confidence in getting colorectal cancer screening.
Means will be compared between all three study groups.
|
Immediately post-intervention
|
|
Affect
Time Frame: Immediately post-intervention
|
Using the Positive and Negative Affect Schedule, we assessed the strength of 5 positive (happy, proud, strong, inspired, hopeful) and 5 negative (angry, guilty, sad, nervous, afraid) emotions felt during the assigned reading (1=Not at all - 7=Extremely).
Higher mean subscale scores reflect stronger positive and negative emotions.
Means will be compared between all three study groups.
|
Immediately post-intervention
|
|
Defensive Information Processing
Time Frame: Immediately post-intervention
|
Seven scales assessing defensive information processing will be assessed using previously validated measures for opt-out behavior (3 items), opt-out information (1 item), blunting (2 items), self-exemption (5 items), deny immediacy (3 items), counterarguing (4 items), and minimize the harm (2 items).
Response options range from 1=strongly disagree to 7=strongly agree.
Mean scores are created for each scale and higher scores reflect greater defensive information processing.
Means will be compared between all three study groups.
|
Immediately post-intervention
|
|
Absolute Perceived Susceptibility to Colon Cancer
Time Frame: Immediately post-intervention
|
Absolute perceived risk was assessed with three items: I am at risk for developing colorectal cancer, If I do not get screened regularly, I would feel vulnerable to developing colorectal cancer, If I do not get screened regularly, it is likely that I will develop colorectal cancer.
Response options range from 1=strongly disagree to 5=strongly agree.
Mean scale scores were created and higher scores reflect greater perceived susceptibility to colorectal cancer.
Mean scores will be compared between all three study groups.
|
Immediately post-intervention
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Social Influence
Time Frame: Immediately post-intervention
|
Social influence will be assessed with three items developed for this study based on standard measures that include physician, family, and friends as important social referents encouraging colorectal cancer screening.
Response options range from 1=strongly disagree to 7=strongly agree.
Mean scores were created and higher scores reflect greater perceived social influence for getting screened for colorectal cancer.
Means will be compared between all three study groups.
|
Immediately post-intervention
|
|
Worry
Time Frame: Immediately post-intervention
|
Worry was assessed with four items regarding worry about getting colorectal cancer, having a test that shows they have colorectal cancer, concern that colorectal cancer screening will be physically uncomfortable, and concern that there could be complications from the test.
Response options ranged from 1=strongly disagree to 5=strongly agree.
Mean scores were created (Range 1-5); higher scores reflect greater worry.
Means will be compared between all three study groups.
|
Immediately post-intervention
|
|
Perceived Benefits and Barriers of Colorectal Cancer Screening
Time Frame: Immediately post-intervention
|
Perceived colorectal cancer screening benefits (8 items) barriers (6 items) are assessed with items from previously validated scales.
Response options range from 1=strongly disagree to 7=strongly agree.
Mean scores were created for each scale; higher scores reflect greater perceived benefits and barriers of getting screened.
Means will be compared between all three study groups.
|
Immediately post-intervention
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Amy McQueen, PhD, Washington University School of Medicine
Publications and helpful links
General Publications
- Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988 Jun;54(6):1063-70. doi: 10.1037//0022-3514.54.6.1063.
- Crawford JR, Henry JD. The positive and negative affect schedule (PANAS): construct validity, measurement properties and normative data in a large non-clinical sample. Br J Clin Psychol. 2004 Sep;43(Pt 3):245-65. doi: 10.1348/0144665031752934.
- Weinstein ND, Kwitel A, McCaul KD, Magnan RE, Gerrard M, Gibbons FX. Risk perceptions: assessment and relationship to influenza vaccination. Health Psychol. 2007 Mar;26(2):146-51. doi: 10.1037/0278-6133.26.2.146.
- Sestir M, Green MC. You are who you watch: Identification and transportation effects on temporary self-concept. Social Influence 5(4): 272-88, 2010.
- Green MC, Brock TC. The role of transportation in the persuasiveness of public narratives. J Pers Soc Psychol. 2000 Nov;79(5):701-21. doi: 10.1037//0022-3514.79.5.701.
- McQueen A, Kreuter MW, Kalesan B, Alcaraz KI. Understanding narrative effects: the impact of breast cancer survivor stories on message processing, attitudes, and beliefs among African American women. Health Psychol. 2011 Nov;30(6):674-82. doi: 10.1037/a0025395. Epub 2011 Sep 5.
- McQueen A, Kreuter MW. Women's cognitive and affective reactions to breast cancer survivor stories: a structural equation analysis. Patient Educ Couns. 2010 Dec;81 Suppl:S15-21. doi: 10.1016/j.pec.2010.08.015. Epub 2010 Sep 17.
- McQueen A, Vernon SW, Swank PR. Construct definition and scale development for defensive information processing: an application to colorectal cancer screening. Health Psychol. 2013 Feb;32(2):190-202. doi: 10.1037/a0027311. Epub 2012 Feb 20.
- McQueen A, Swank PR, Vernon SW. Examining patterns of association with defensive information processing about colorectal cancer screening. J Health Psychol. 2014 Nov;19(11):1443-58. doi: 10.1177/1359105313493649. Epub 2013 Jul 17.
- McQueen A, Tiro JA, Vernon SW. Construct validity and invariance of four factors associated with colorectal cancer screening across gender, race, and prior screening. Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2231-7. doi: 10.1158/1055-9965.EPI-08-0176.
- Vernon SW, Meissner H, Klabunde C, Rimer BK, Ahnen DJ, Bastani R, Mandelson MT, Nadel MR, Sheinfeld-Gorin S, Zapka J. Measures for ascertaining use of colorectal cancer screening in behavioral, health services, and epidemiologic research. Cancer Epidemiol Biomarkers Prev. 2004 Jun;13(6):898-905. No abstract available.
- McQueen A, Caburnay C, Kreuter M, Sefko J. Improving Adherence to Colorectal Cancer Screening: A Randomized Intervention to Compare Screener vs. Survivor Narratives. J Health Commun. 2019;24(2):141-155. doi: 10.1080/10810730.2019.1587109. Epub 2019 Mar 29.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HRPO201501019
- R21CA187608 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastrointestinal Neoplasms
-
Medstar Health Research InstituteRecruitingGastrointestinal Cancer | Gastrointestinal Tumor | Gastrointestinal Surgery | Gastrointestinal Tumor SurgeryUnited States
-
Sun Yat-sen UniversityUnknownGastrointestinal CancersChina
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisCompleted
-
Peking University Cancer Hospital & InstituteActive, not recruitingGastrointestinal CancerChina
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdJiangsu Alphamab Biopharmaceuticals Co., LtdTerminatedAdvanced Gastrointestinal TumorsChina
-
Boehringer IngelheimCompletedGastrointestinal Cancer, MetastaticBelgium, United States, France, Japan, China
-
Taiho Oncology, Inc.CompletedAdvanced Gastrointestinal TumorsUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Henan Cancer HospitalUnknownAdvanced Gastrointestinal TumorsChina
-
Apceth GmbH & Co. KGTerminatedAdvanced Gastrointestinal CancerGermany
Clinical Trials on Education information
-
University of Michigan Rogel Cancer CenterAgency for Healthcare Research and Quality (AHRQ)CompletedA Novel Health Information Technology System (BMT Roadmap) for Pediatric BMT Patients and CaregiversLymphoma | Leukemia | Brain TumorUnited States
-
University of PennsylvaniaNew York Blood CenterCompletedBehavior and Behavior Mechanisms | Information LiteracyUnited States
-
University of OxfordWyeth is now a wholly owned subsidiary of Pfizer; PfizerCompleted
-
Mogens Berg LaursenAarhus University Hospital; University of Southern DenmarkCompletedPatellofemoral Pain SyndromeDenmark
-
University of MelbourneCompletedKnee Osteoarthritis | Patient EmpowermentAustralia
-
Ankara Medipol UniversityCompletedObstetric Care of the Giving BirthTurkey
-
University Hospitals, LeicesterNational Institute for Health Research, United Kingdom; University of LeicesterCompleted
-
Çanakkale Onsekiz Mart UniversityCompleted
-
The University of Texas Health Science Center,...Completed
-
University of TorontoCompleted